These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 25917024)

  • 1. Preoperative skin antiseptics for prevention of cardiac implantable electronic device infections: a historical-controlled interventional trial comparing aqueous against alcoholic povidone-iodine solutions.
    Da Costa A; Tulane C; Dauphinot V; Terreaux J; Romeyer-Bouchard C; Gate-Martinet A; Levallois M; Isaaz K
    Europace; 2015 Jul; 17(7):1092-8. PubMed ID: 25917024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Cardiac Implantable Electronic Device Infections: Single Operator Technique with Use of Povidone-Iodine, Double Gloving, Meticulous Aseptic/Antiseptic Measures and Antibiotic Prophylaxis.
    Manolis AS; Melita H
    Pacing Clin Electrophysiol; 2017 Jan; 40(1):26-34. PubMed ID: 27996097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.
    Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bundled preparation of skin antisepsis decreases the risk of cardiac implantable electronic device-related infection.
    Chen HC; Chen MC; Chen YL; Tsai TH; Pan KL; Lin YS
    Europace; 2016 Jun; 18(6):858-67. PubMed ID: 26056185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study.
    Klug D; Balde M; Pavin D; Hidden-Lucet F; Clementy J; Sadoul N; Rey JL; Lande G; Lazarus A; Victor J; Barnay C; Grandbastien B; Kacet S;
    Circulation; 2007 Sep; 116(12):1349-55. PubMed ID: 17724263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.
    Shariff N; Eby E; Adelstein E; Jain S; Shalaby A; Saba S; Wang NC; Schwartzman D
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):783-9. PubMed ID: 25845917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of povidone-iodine pocket irrigation use on pacemaker and defibrillator infections.
    Lakkireddy D; Valasareddi S; Ryschon K; Basarkodu K; Rovang K; Mohiuddin SM; Hee T; Schweikert R; Tchou P; Wilkoff B; Natale A; Li H
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):789-94. PubMed ID: 16105006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative antibiotic prophylaxis in the prevention of cardiac implantable electronic device infection.
    Madadi S; Kafi M; Kheirkhah J; Azhari A; Kiarsi M; Mehryar A; Fazelifar A; Alizadehdiz A; Emkanjoo Z; Haghjoo M
    Pacing Clin Electrophysiol; 2019 Feb; 42(2):161-165. PubMed ID: 30575054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection.
    Calderón-Parra J; Sánchez-Chica E; Asensio-Vegas Á; Fernández-Lozano I; Toquero-Ramos J; Castro-Urda V; Royuela-Vicente A; Ramos-Martínez A
    Rev Esp Cardiol (Engl Ed); 2019 Oct; 72(10):806-812. PubMed ID: 30340923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection control in implantation of cardiac implantable electronic devices: current evidence, controversial points, and unresolved issues.
    Korantzopoulos P; Sideris S; Dilaveris P; Gatzoulis K; Goudevenos JA
    Europace; 2016 Apr; 18(4):473-8. PubMed ID: 26516219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections.
    Welch M; Uslan DZ; Greenspon AJ; Sohail MR; Baddour LM; Blank E; Carrillo RG; Danik SB; Del Rio A; Hellinger W; Le KY; Miro JM; Naber C; Peacock JE; Vikram HR; Tseng CH; Prutkin JM;
    Pacing Clin Electrophysiol; 2014 Aug; 37(8):955-62. PubMed ID: 24665867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective comparative analysis of cardiovascular implantable electronic device infections with and without the use of antibacterial envelopes.
    Hassoun A; Thottacherry ED; Raja M; Scully M; Azarbal A
    J Hosp Infect; 2017 Mar; 95(3):286-291. PubMed ID: 28131641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency.
    Pecha S; Aydin MA; Yildirim Y; Sill B; Reiter B; Wilke I; Reichenspurner H; Treede H
    Europace; 2013 Aug; 15(8):1205-9. PubMed ID: 23426553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study.
    Malagù M; Vitali F; Brieda A; Cimaglia P; De Raffele M; Tazzari E; Musolino C; Balla C; Serenelli M; Cultrera R; Rapezzi C; Bertini M
    Europace; 2022 Mar; 24(3):413-420. PubMed ID: 34487163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry.
    Uslan DZ; Gleva MJ; Warren DK; Mela T; Chung MK; Gottipaty V; Borge R; Dan D; Shinn T; Mitchell K; Holcomb RG; Poole JE
    Pacing Clin Electrophysiol; 2012 Jan; 35(1):81-7. PubMed ID: 22077194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.
    de Oliveira JC; Martinelli M; Nishioka SA; Varejão T; Uipe D; Pedrosa AA; Costa R; D'Avila A; Danik SB
    Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):29-34. PubMed ID: 19808441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
    Tarakji KG; Mittal S; Kennergren C; Corey R; Poole JE; Schloss E; Gallastegui J; Pickett RA; Evonich R; Philippon F; McComb JM; Roark SF; Sorrentino D; Sholevar D; Cronin E; Berman B; Riggio D; Biffi M; Khan H; Silver MT; Collier J; Eldadah Z; Wright DJ; Lande JD; Lexcen DR; Cheng A; Wilkoff BL;
    N Engl J Med; 2019 May; 380(20):1895-1905. PubMed ID: 30883056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis.
    Koerber SM; Turagam MK; Winterfield J; Gautam S; Gold MR
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):609-615. PubMed ID: 29364546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study.
    Deharo JC; Quatre A; Mancini J; Khairy P; Le Dolley Y; Casalta JP; Peyrouse E; Prévôt S; Thuny F; Collart F; Raoult D; Habib G; Franceschi F
    Heart; 2012 May; 98(9):724-31. PubMed ID: 22523057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Implantable Electronic Device Infections due to Propionibacterium Species.
    El Rafei A; Desimone DC; Sohail MR; Desimone CV; Steckelberg JM; Wilson WR; Baddour LM
    Pacing Clin Electrophysiol; 2016 Jun; 39(6):522-30. PubMed ID: 26970081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.